{"data":{"id":864,"lang":"en","title":"Scientists Reveal How Alzheimer's Drug Lecanemab Actually Works, Opening Door to New Therapies","summary":"VIB-KU Leuven researchers discovered lecanemab clears brain plaques by activating immune cells through its Fc fragment, opening the door to next-generation Alzheimer's treatments.","category":"science","category_label":"Science","published_at":"2026-03-17T20:02:03Z","updated_at":"2026-03-17T20:02:03Z","url":"https://techtools.cz/tools/news/article/864-scientists-reveal-how-alzheimer-s-drug-lecanemab-actually-works-opening-door-to","api_url":"https://techtools.cz/news-api/v1/articles/864?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/864.md?lang=en","image_url":"https://www.sciencedaily.com/images/1920/dementia-memory-treatment-brain-puzzle.webp","word_count":139,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260317064457.htm","domain":"sciencedaily.com"},{"url":"https://www.nature.com/articles/s41593-025-02125-8","domain":"nature.com"}],"translation":{"lang":"cs","id":891,"title":"Vědci odhalili, jak lék na Alzheimerovu chorobu lecanemab skutečně funguje, a otevírají cestu k novým terapiím","url":"https://techtools.cz/tools/news/clanek/891-vedci-odhalili-jak-lek-na-alzheimerovu-chorobu-lecanemab-skutecne-funguje-a","api_url":"https://techtools.cz/news-api/v1/articles/891?lang=cs"},"content":"Researchers at the VIB-KU Leuven Center for Brain \u0026 Disease Research have uncovered the hidden mechanism behind lecanemab (Leqembi), the FDA-approved Alzheimer's drug. The study, published in Nature Neuroscience and led by Prof. Bart De Strooper, found that the drug clears toxic amyloid plaques by activating the brain's immune cells — microglia — through a specific part of the antibody called the Fc fragment.\n\nUsing hybrid mouse models containing human microglial cells, co-first authors Dr. Giulia Albertini and Magdalena Zielonka showed the Fc fragment acts as a trigger that reprograms microglia into an active plaque-clearing state. The team also identified SPP1/osteopontin as a key molecular factor driving effective amyloid removal.\n\nThe discovery is significant because it suggests future Alzheimer's therapies could potentially activate microglia directly, bypassing the need for antibodies altogether — a path that could lead to cheaper, more accessible treatments."}}